Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD

Calamos Advisors LLC reduced its stake in Gilead Sciences, Inc. by 3.9% in the fourth quarter, selling 9,121 shares and holding 225,569 shares valued at $27.68 million. Despite this, other institutional investors significantly increased their holdings in GILD. The company reported strong financial performance, with earnings beating estimates and an increased quarterly dividend, while analysts maintain a “Moderate Buy” rating with an average target price of $157.35.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin